Skip to content
Log in
Sponsored Artificial Intelligence: A Modern Approach, Global Edition Artificial Intelligence: A Modern Approach, Global Edition

Author

U. Pagotto

View on Semantic Scholar

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Preoperative parathyroid imaging in CKD-related secondary hyperparathyroidism: a systematic review and diagnostic test accuracy network meta-analysis

ABSTRACT Background and aims In secondary hyperparathyroidism (SHPT), imaging must characterize multifocal disease and identify ectopic or supernumerary tissue before surgery, but the comparative accuracy and optimal hierarchy of available modalities remain uncertain. We compared the main preoperative imaging technique...

D. Vetrano, Simona Barbuto, Anna Mistretta et al. · 0 citations
Open access Sep 2026

A comparative real-world analysis of finerenone and steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease

Background Finerenone and steroidal mineralocorticoid receptor antagonists (sMRAs) reduce proteinuria in chronic kidney disease (CKD), but direct comparative data from routine clinical practice remain limited. The objective of this study was to compare the effectiveness, hemodynamic effects, kidney function trajectory,...

D. Vetrano, G. Cianciolo, Simona Barbuto et al. · 0 citations
Case report Open access Sep 2026

Case Report: Reopening the anabolic window — romosozumab added to ongoing denosumab for severe osteoporosis in two kidney transplant recipients

Kidney transplant recipients develop disorders of mineral and bone metabolism that further impair bone strength, leading to osteoporosis and a high fracture risk. However, evidence in this setting is limited. Romosozumab, a sclerostin inhibitor with both anabolic and antiresorptive effects, is an attractive option, but...

Simona Barbuto, Paolo Mastromauro, G. Zavatta et al. · 0 citations
Open access Aug 2026

Longitudinal changes in cardiorenal risk scores after SGLT2 inhibitor initiation in patients with CKD with and without type 2 diabetes.

BACKGROUND Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have become the standard of care in managing chronic kidney disease (CKD) and heart failure (HF), both in patients with and without type 2 diabetes mellitus (T2DM). Nonetheless, identifying those at persistent high cardiovascular (CV) and renal risk remains...

I. Capelli, D. Vetrano, D. Ribichini et al. · 0 citations
Open access Aug 2026

AD18 Integrated steroidomic and untargeted metabolomic profiling reveals distinct circulating signatures of adrenocortical carcinoma

Adrenal tumours display marked biological heterogeneity, making the distinction between benign and malignant lesions challenging. Liquid chromatography–high-resolution mass spectrometry (LC-HRMS) enables simultaneous investigation of steroidomic and broader metabolomic alterations. To identify integrated c...

G. Galante, T. Sénard, A. Gennai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.